login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CALIDI BIOTHERAPEUTICS INC (CLDI) Stock News
USA
- NYSEARCA:CLDI -
US3207034089
-
Common Stock
1.52
USD
+0.08 (+5.56%)
Last: 10/23/2025, 8:04:03 PM
1.54
USD
+0.02 (+1.32%)
After Hours:
10/23/2025, 8:04:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CLDI Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Benzinga
- Mentions:
COR
PHR
FBIO
RLMD
...
12 Health Care Stocks Moving In Thursday's After-Market Session
2 months ago - By: Calidi Biotherapeutics, Inc
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2 months ago - By: Calidi Biotherapeutics, Inc
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
2 months ago - By: Benzinga
- Mentions:
NBY
TRIB
WINT
THAR
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
2 months ago - By: Calidi Biotherapeutics, Inc
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
3 months ago - By: The Motley Fool
Calidi Loss Down 23 Percent in Fiscal Q2
3 months ago - By: Calidi Biotherapeutics, Inc
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
3 months ago - By: ACCESS Newswire
- Mentions:
ATOS
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
3 months ago - By: Calidi Biotherapeutics, Inc
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025
3 months ago - By: Calidi Biotherapeutics, Inc
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24
Please enable JavaScript to continue using this application.